Leases

6 Months Ended

Dec. 25, 2021

8. Leases

Our leases mainly include our worldwide office and research and development facilities which are all classified as operating leases. Certain leases include renewal options that are under our discretion. The leases expire at various dates through fiscal year 2029, some of which include options to extend the lease for up to 5 years. For the six months ended December 25, 2021 and December 26, 2020, we recorded approximately $5.7 million and $5.0 million, respectively, of operating leases expense. Our short-term leases are immaterial.

As of December 25, 2021, and June 26, 2021, the components of leases and lease costs are as follows (in millions):


	December		June
	2021		2021
Operating lease right-of-use assets	$	44.0	$	31.7
Operating lease liabilities	$	9.5	$	9.3
Operating lease liabilities, long-term		35.2		24.0
Total operating lease liabilities	$	44.7	$	33.3

Supplemental cash flow information related to leases, including from acquisitions, is as follows (in millions):


	Six Months Ended
	December
	2021		2020
Cash paid for operating leases included in operating cash flows	$	5.4	$	3.9
Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets		17.6		21.7

As of December 25, 2021, the weighted average remaining lease term is 6.2 years, and the weighted average discount rate is 3.8%.

Future minimum lease payments for the operating lease liabilities are as follows (in millions):


	Operating
	Lease
Fiscal Year	Payments
Remainder of 2022	$	5.9
2023		8.6
2024		8.2
2025		6.8
2026		6.5
Thereafter		14.2
Total future minimum operating lease payments		50.2
Less: interest		(5.5	)
Total lease liabilities	$	44.7